Clinical Trials Logo

Low Back Pain clinical trials

View clinical trials related to Low Back Pain.

Filter by:

NCT ID: NCT03409783 Withdrawn - Clinical trials for Chronic Low Back Pain

Enso Pilot Study for Chronic Low Back Pain

Start date: February 14, 2018
Phase: N/A
Study type: Interventional

Enso is a portable device for the treatment of chronic and acute types of musculoskeletal pain. This study is being designed as a single blind, sham-controlled randomized clinical trial.

NCT ID: NCT03301766 Withdrawn - Low Back Pain Clinical Trials

Adjunctive 5% Lidocaine Patches for Acute Non-radicular Low Back Pain in Emergency Department Patients

Start date: March 10, 2017
Phase: Phase 4
Study type: Interventional

This study will evaluate the addition of lidocaine % transdermal patches to standard therapy in the treatment of acute non-radicular low back pain in patients discharged from the Emergency Department. In addition to standard therapy, half of the participants will receive medicated patches while the other half will receive non-medicated patches.

NCT ID: NCT03088774 Withdrawn - Low Back Pain Clinical Trials

Comparing Satisfaction With a Participatory Driven Web-application and a Standard Website

Start date: January 25, 2021
Phase: N/A
Study type: Interventional

This project studies the effects of involving patients in the development of a web-application.

NCT ID: NCT02932020 Withdrawn - Low Back Pain Clinical Trials

AlloGen-LI Treatment of Spinal Stenosis

Start date: October 2016
Phase: N/A
Study type: Interventional

In this pilot study, investigators will test the efficacy of AlloGen-LI, an allograft derived from amniotic fluid, injected into the epidural space at the level of spinal stenosis as an anti-inflammatory treatment to relieve back and leg pain symptoms in patients with spinal stenosis and/or disc herniation. The patients will be followed for 12 weeks. The effect of this treatment will be examined by patient reported changes in pain and disability utilizing validated outcome measures, and MRI imaging evaluating changes in contrast enhancement and T2 signal related to that reflect inflammation and degeneration.

NCT ID: NCT02887534 Withdrawn - Acute Muscle Pain Clinical Trials

Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain

Start date: November 2016
Phase: Phase 2
Study type: Interventional

A phase 2 randomized clinical trial to evaluate efficacy and safety of SPARC1401 at three dose levels in patients with acute low back pain

NCT ID: NCT02611583 Withdrawn - Low Back Pain Clinical Trials

TENS Treatment Plus Ibuprofen for the Treatment of Acute Back Pain in the ED

Start date: June 24, 2016
Phase: N/A
Study type: Interventional

Patients presenting to the ED with a chief complaint of acute low back pain and whom the providing physician feels symptomatic treatment is appropriate in the ED will be screened for inclusion in the study. The purpose of the study is to compare Transcutaneous Electrical Nerve Stimulation (TENS) as an adjunct to ibuprofen in the treatment of acute low back pain in the emergency department. Therefore, the aim of this prospective, randomized, double blind study is to evaluate the efficacy of ED administered TENS in acute low back pain patients during their ED visit.

NCT ID: NCT02606786 Withdrawn - Clinical trials for Pregnancy-related Low Back Pain

Effectiveness of Lumbopelvic Stabilization Exercises for Pregnancy-related Low Back Pain

Start date: March 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the effectiveness of lumbopelvic stabilization exercises on women who have undergone Caesarian sections on: 1) disability using the Modified Oswestry Low Back Disability Index (OSW), 2) pain according to the Numeric Pain Rating Scale (NPRS), 3) percent change of muscle thickness of the deep abdominals using ultrasound imaging, and 4) perceived improvement using the Global Rating of Change (GROC).

NCT ID: NCT02568826 Withdrawn - Low Back Pain Clinical Trials

Tolerability, Safety and Activity of a Muscle Relaxant Molecule IDN5243 in Patients With Low Back Pain

IDN5243inLBP
Start date: April 2016
Phase: Phase 2
Study type: Interventional

This is a prospective cohort study, open-label, uncontrolled proof of concept trial. The trial objective is to evaluate the analgesic tolerability, safety and activity of IDN 5243 (3-glycosyl-3-O-demethylthiocolchicine derivative)administered intramuscularly at 4 mg b.i.d. for 5 days in the morning (8.00-10.00 AM) and in the evening (6.00-8.00 PM) in subjects with Low Back Pain (LBP).

NCT ID: NCT02490722 Withdrawn - Low Back Pain Clinical Trials

Effect of Patient Education on Functions in Patients With Non-specific and/or Degenerative Low Back Pain

Start date: January 2016
Phase: N/A
Study type: Interventional

The aim of this study is to investigate effects of interdisciplinary group based patient education in patients with low back pain. The patients will be recruited to four group based patient education lessons during a two months period. The study is a randomized controlled trial and the patients will be randomized to standard treatment or standard treatment and patient education. The patient education will be led by physiotherapists, nurses and physicians. The outcomes are functions, pain, quality of life, self-efficacy, and depression. The data are reported in questionnaires.

NCT ID: NCT02427438 Withdrawn - Low Back Pain Clinical Trials

Home Program Education for Patients With Low Back Pain

Start date: February 2015
Phase: N/A
Study type: Interventional

The primary purpose of this study is to assess the effect size of the change in Oswestry Disability Questionnaire (ODQ) score over the 8 week follow-up period between the video based instruction or standard of care hand-out with pictures and written instructions for subjects meeting the clinical prediction rule for lumbar stabilization. The second purpose will be to determine if there is a subset of physical examination and self-reported variables that are associated with having a successful result (ODQ improvement by at least 6 points) and if the subset of variables are affected by whether or not the subject was in the intervention (video) or control (handout) group.